Companies: 10,795·Total market cap: $144.5T
Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc.

LIPOOTCHealthcare● Active
$0.09
$-0.01(-10.00%)
Market Cap$415875
P/E Ratio—
52W High$3.17
52W Low$0.02
SEC Filings

Lipella Pharmaceuticals Inc. (LIPO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001347242 · LIPO · OTC · as of Jun 9, 2026

Filing snapshot

224
Total Filings
8-K
Latest Form
2026-03-31
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001347242 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-03-28
Fiscal Year End
Mar 28, 2025
Accession No.
0001753926-25-000507
Primary Document
g084734_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001347242 · Accession 0001753926-25-000507

Latest Key Filings

10-QQuarterly Report
FORM 10Q
2025-11-14
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-03-31Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-03-31
View
8-KCurrent Report
8-K
2026-02-04
View
10-QQuarterly Report
FORM 10Q
2025-11-14
View
8-KCurrent Report
8-K
2025-10-21
View
8-KCurrent Report
8-K
2025-10-09
View
25-NSE25-NSE
25-NSE
2025-10-06
View
8-KCurrent Report
8-K
2025-09-18
View
10-QQuarterly Report
10-Q
2025-08-14
View
8-KCurrent Report
8-K
2025-06-25
View
8-KCurrent Report
FORM 8-K
2025-06-20
View
8-KCurrent Report
8-K
2025-06-16
View
PRE 14APRE 14A
PRE 14A
2025-06-10
View
8-KCurrent Report
8-K
2025-05-16
View
8-KCurrent Report
8-K
2025-05-15
View
10-QQuarterly Report
10-Q
2025-05-14
View
Showing 1–15 of 197 filingsForm 4 / 144 hidden· 224 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001347242  |  Exchange: OTC · Healthcare

Lipella Pharmaceuticals Inc. (OTC: LIPO) has submitted 224 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001347242, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Lipella Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Lipella Pharmaceuticals Inc. 10-K was filed on 2025-03-28 for fiscal year ending 2025. Historical LIPO 10-K annual reports are available from 2005 through 2025.

Investors researching Lipella Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
NKGN SEC Filings →SLRX SEC Filings →GTBP SEC Filings →INDP SEC Filings →ARTL SEC Filings →AZTR SEC Filings →VRAX SEC Filings →PTIX SEC Filings →
→ LIPO Financials→ LIPO Earnings→ LIPO Insider Trades

Frequently Asked Questions

LIPO SEC Filings · 8 questions

Lipella Pharmaceuticals Inc. (LIPO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 224 filings and access original documents at no cost. Lipella Pharmaceuticals Inc.'s CIK is 0001347242.

LIPO SEC filingsLipella Pharmaceuticals Inc. SEC documentsfind LIPO 10-K